$Geron (GERN.US)$ Geron wins FDA AdCom backing for blood can...
$Geron (GERN.US)$ Geron wins FDA AdCom backing for blood cancer drug A group of independent experts at the FDA voted in favor of Geron's (NASDAQ:GERN (https://seekingalpha.com/symbol/GERN)) marketing application for its blood cancer therapy imetelstat on Thursday, paving the way for the company to receive a potential U.S. regulatory nod for the drug this year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1326Followers
79Following
9348Visitors
Follow